Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Kooistra

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 1997
The management of iron metabolism in recombinant human erythropoietin treated dialysis patients by Dutch nephrologistsM P Kooistra, J J Marx
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 30, 1998
The absorption of iron is disturbed in recombinant human erythropoietin-treated peritoneal dialysis patientsM P Kooistra, J J Marx
Advances in Nephrology From the Necker Hospital|November 6, 2001
The beat of hemodialysis: frequent, prolonged, or frequent and prolonged?M P Kooistra, P F Vos
Nephron|January 1, 1991
The response to recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levelsM P Kooistra, A Struyvenberg, A van Es
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 13, 2001
Clinical outcome of daily dialysisP F Vos, O Zilch, M P Kooistra
British Journal of Haematology|December 1, 1991
Iron metabolism in patients with the anaemia of end-stage renal disease during treatment with recombinant human erythropoietinM P Kooistra, A van Es, A Struyvenberg, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 1998
Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of lifeM P Kooistra, J Vos, H A Koomans, et al.
Contributions to Nephrology|January 1, 1992
Amelioration of cardiac function by L-carnitine administration in patients on haemodialysisA van Es, F C Henny, M P Kooistra, et al.
The Netherlands Journal of Medicine|June 22, 2016
Full-dose sofosbuvir and daclatasvir for chronic hepatitis C infection in haemodialysis patientsT J G Gevers, D Burger, E Schipper-Reintjes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Low-dose aspirin does not prevent thrombovascular accidents in low-risk haemodialysis patients during treatment with recombinant human erythropoietinM P Kooistra, A van Es, J J Marx, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 1997
The management of iron metabolism in recombinant human erythropoietin treated dialysis patients by Dutch nephrologistsM P Kooistra, J J Marx
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 30, 1998
The absorption of iron is disturbed in recombinant human erythropoietin-treated peritoneal dialysis patientsM P Kooistra, J J Marx
Advances in Nephrology From the Necker Hospital|November 6, 2001
The beat of hemodialysis: frequent, prolonged, or frequent and prolonged?M P Kooistra, P F Vos
Nephron|January 1, 1991
The response to recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levelsM P Kooistra, A Struyvenberg, A van Es
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 13, 2001
Clinical outcome of daily dialysisP F Vos, O Zilch, M P Kooistra
British Journal of Haematology|December 1, 1991
Iron metabolism in patients with the anaemia of end-stage renal disease during treatment with recombinant human erythropoietinM P Kooistra, A van Es, A Struyvenberg, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 1998
Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of lifeM P Kooistra, J Vos, H A Koomans, et al.
Contributions to Nephrology|January 1, 1992
Amelioration of cardiac function by L-carnitine administration in patients on haemodialysisA van Es, F C Henny, M P Kooistra, et al.
The Netherlands Journal of Medicine|June 22, 2016
Full-dose sofosbuvir and daclatasvir for chronic hepatitis C infection in haemodialysis patientsT J G Gevers, D Burger, E Schipper-Reintjes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Low-dose aspirin does not prevent thrombovascular accidents in low-risk haemodialysis patients during treatment with recombinant human erythropoietinM P Kooistra, A van Es, J J Marx, et al.
Pageof 2